The LDHA, LDHB, LDHL, and hicD genes are involved in this pathway and exchange metabolic fuel with the tumor stroma, making them promising targets for CRC chemotherapeutic drugs [96]. This evidence concerns the gene LDHB and colorectal carcinoma.